We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MASI
76
DELISTED
Masimo
MASI
$28.2M 0.41%
332,442
+50,156
+18% +$4.35M
BIG
77
DELISTED
Big Lots, Inc.
BIG
$27.9M 0.41%
496,962
-7,291
-1% -$395K
NTGR icon
78
NETGEAR
NTGR
$602M
$27.4M 0.4%
465,588
+774
+0.2% +$39.6K
BRKR icon
79
Bruker
BRKR
$8.86B
$27M 0.4%
785,978
-20,170
-3% -$661K
RHP icon
80
Ryman Hospitality Properties
RHP
$7.99B
$26.9M 0.39%
390,264
-5,736
-1% -$383K
APD icon
81
Air Products & Chemicals
APD
$65.8B
$26.6M 0.39%
161,978
+278
+0.2% +$44.3K
GIS icon
82
General Mills
GIS
$20.3B
$26.4M 0.39%
445,147
-5,618
-1% -$304K
DE icon
83
Deere & Co
DE
$161B
$26M 0.38%
166,390
-7,535
-4% -$1.05M
TXRH icon
84
Texas Roadhouse
TXRH
$13B
$24.5M 0.36%
465,438
-6,996
-1% -$354K
COL
85
DELISTED
Rockwell Collins
COL
$24.3M 0.36%
179,005
-81,091
-31% -$10.9M
CAKE icon
86
Cheesecake Factory
CAKE
$4.26B
$23.9M 0.35%
495,263
+21,802
+5% +$991K
NJR icon
87
New Jersey Resources
NJR
$5.91B
$23.7M 0.35%
590,653
-8,926
-1% -$383K
UMBF icon
88
UMB Financial
UMBF
$11.1B
$23.5M 0.34%
326,583
-10,517
-3% -$772K
COHR
89
DELISTED
Coherent Inc
COHR
$23.4M 0.34%
82,859
-1,774
-2% -$494K
DHR icon
90
Danaher
DHR
$144B
$23.4M 0.34%
284,044
+18,849
+7% +$1.53M
CNS icon
91
Cohen & Steers
CNS
$4.35B
$23.3M 0.34%
493,033
-8,881
-2% -$391K
WSM icon
92
Williams-Sonoma
WSM
$26.9B
$23.2M 0.34%
897,722
-19,434
-2% -$495K
HUBG icon
93
HUB Group
HUBG
$3.13B
$23.1M 0.34%
965,308
+242,202
+33% +$5.33M
FLO icon
94
Flowers Foods
FLO
$1.8B
$23.1M 0.34%
1,195,325
+15,549
+1% +$299K
DORM icon
95
Dorman Products
DORM
$4.24B
$23M 0.34%
376,601
-11,602
-3% -$787K
MORN icon
96
Morningstar
MORN
$6.56B
$22.9M 0.34%
236,040
-1,839
-0.8% -$166K
BMS
97
DELISTED
Bemis
BMS
$22.2M 0.33%
464,108
-16,195
-3% -$749K
HON icon
98
Honeywell
HON
$71.3B
$22.1M 0.32%
159,822
+105,780
+196% +$14.2M
TEN
99
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$22.1M 0.32%
378,075
-9,342
-2% -$552K
SLGN icon
100
Silgan Holdings
SLGN
$4.99B
$21.8M 0.32%
741,885
+36,463
+5% +$1.06M
2 3
4
5 6

Similar funds

GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $12B AUM 27.64% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $12.4B AUM 25.9% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $12.4B AUM 17.21% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.